News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Navidea Biopharmaceuticals Announces Fourth Quarter and Full-Year 2012 Results
March 7, 2013
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced consolidated results for the fourth quarter of 2012 and for the year ended December 31, 2012.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Manufacturing
GSK Commits $30B To Boost US R&D, Manufacturing Operations
September 17, 2025
·
1 min read
·
Tristan Manalac
Manufacturing
Lilly to Bring Nearly 2,500 Jobs to Virginia With $5B Manufacturing Plant
September 17, 2025
·
1 min read
·
Tristan Manalac
Startups
Ollin Emerges From Stealth With $100M To Develop Eye Disease Bispecifics
September 17, 2025
·
2 min read
·
Tristan Manalac
Artificial Intelligence
The Future of Pharma Is Predictive Care Powered by Consumers, AI: PwC
September 17, 2025
·
2 min read
·
Annalee Armstrong
